Home › Overweight › Florida › Miami
Overweight clinical trials in Miami, FL
23 studies for Overweight are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
RecruitingPhase 3
- Southern Clinical Research, Miami
- Research Institute of South Florida, Miami
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- New Horizon Research Center, Miami
- Research Institute of South Florida, Miami
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
RecruitingPhase 3
- Bioclinical Research Alliance, Miami
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
- New Horizon Research Center, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecruitingPhase 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RecruitingPhase 3
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
RecruitingPhase 3
- International Research Associates LLC, Miami
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Miami
Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
RecruitingObservational studyHealthy volunteers welcome
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- New Horizon Research Center, Miami
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- New Horizon Research Center, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecruitingPhase 3
- Optimus U Corporation, Miami
- Research Institute of South Florida, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- San Marcus Research Clinic Inc, Miami
- Optimus U Corporation, Miami
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RecruitingPhase 3
- PharmaDev Clinical Research Institute LLC, Miami
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
RecruitingPhase 1
- Clinical Pharmacology of Miami, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- BioMed Research & Medical Center, Miami
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
RecruitingPhase 3
- PharmaDev Clinical Research Institute LLC, Miami
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Miami
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
RecruitingObservational studyHealthy volunteers welcome
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study
RecruitingObservational studyHealthy volunteers welcome
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL29 studies
- Orlando, FL27 studies
- Dallas, TX23 studies
- Washington, DC20 studies
- Atlanta, GA20 studies
- Austin, TX19 studies
- Las Vegas, NV19 studies
- Jacksonville, FL19 studies
- New York City, NY19 studies
- Los Angeles, CA18 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
- COPD20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.